Register Log-in Investor Type

Events

ShareSoc Webinar with Midatech Pharma PLC (MTPH) – 18 November 2021

Description

Company: Midatech Pharma PLC (MTPH)
Date:
18 November 2021
Time: 5pm
Format: Webinar
Presenter: Stephen Stamp (CEO & CFO)

Company Information: Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The Company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

The Company has developed three in-house technology platforms, each with its own unique mechanism to improve delivery of medications to sites of disease. All of the Company’s technologies have successfully entered human use in the clinic, providing important validation of the potential for each platform:

  • Q-Sphera™ platform: a disruptive micro-technology used for sustained release to prolong and control the release of therapeutics over an extended period of time (from weeks to months).
  • MidaSolve™ platform: an innovative nanotechnology used to dissolve insoluble drugs so that they can be administered in liquid form directly and locally into tumours.
  • MidaCore™ platform: a leading-edge nanotechnology used for targeting medications to sites of disease.

The platform nature of the technologies offers the potential to develop multiple drug assets rather than being reliant on a limited number of programmes. Midatech’s technologies are supported by 36 patent families including 120 granted patents and an additional 70 patent applications. Midatech’s headquarters and R&D facility is in Cardiff, UK.

Speakers

Stephen Stamp

Mr Stamp is an experienced public company CFO and has held senior positions in a number of healthcare companies in the UK and the US, including CFO of Shire plc; COO of Xanodyne Pharmaceuticals Inc; CFO of Assurex Health Inc and CFO (and latterly CEO) of Ergomed plc. He has also been CFO of Regus plc (now IWG plc) and EZCORP Inc. Mr Stamp also has considerable M&A experience, having worked for Lazard in London.

He is a Chartered Accountant and qualified with KPMG and has a BA (Econ) from the University of Manchester.

This is a free event.

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…